Burning Rock Biotech (BNR) Enterprise Value (2019 - 2025)

Burning Rock Biotech's Enterprise Value history runs 7 years deep, the most recent figure standing at -$67.8 million for Q4 2025.

• In Q4 2025, Enterprise Value rose 6.69% year-over-year to -$67.8 million; the TTM figure through Dec 2025 stood at -$67.8 million (up 6.69% YoY), while the FY2025 annual figure was -$68.2 million, up 4.65% from the prior year.
• Enterprise Value was -$67.8 million for Q4 2025 at Burning Rock Biotech, down from -$65.7 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$63.2 million in Q2 2025 to a low of -$322.5 million in Q1 2021.
• Historically, Enterprise Value has averaged -$135.4 million across 5 years, with a median of -$96.0 million in 2023.
• The sharpest annual moves came in 2021 and 2022: Enterprise Value tumbled 517.38% in 2021, then jumped 44.32% in 2022.
• A 5-year view of Enterprise Value shows it stood at -$225.1 million in 2021, then surged by 42.2% to -$130.1 million in 2022, then jumped by 34.32% to -$85.4 million in 2023, then grew by 14.92% to -$72.7 million in 2024, then rose by 6.69% to -$67.8 million in 2025.
• The last three Enterprise Value figures came in at -$67.8 million (Q4 2025), -$65.7 million (Q3 2025), and -$63.2 million (Q2 2025), per Business Quant data.